Explore an invited speaker presentation focusing on TP53 alterations in myelodysplastic neoplasms and acute myeloid leukemia. Gain insights from Joseph Khoury's talk at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting, introduced by Panieh Terraf. Delve into the latest research and clinical implications of TP53 mutations in these hematological malignancies. Learn about the Cancer Genomics Consortium's mission to promote best practices in clinical cancer genomics and their goal of ensuring accurate genomic diagnoses for all cancer patients. Discover how this knowledge contributes to tailoring appropriate therapies for patients with myelodysplastic neoplasms and acute myeloid leukemia.
TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Cancer Genomics Consortium via YouTube
Overview
Syllabus
Invited Speaker Presentation-TP53 alterations in myelodysplastic neoplasms & acute myeloid leukemia
Taught by
Cancer Genomics Consortium
Related Courses
-
NPM1 Mutation in Myeloid Malignancies - Advancing Precision Medicine
-
Clinical, Cytogenetic and Genomic Profiling of B-Other Acute Lymphoblastic Leukemia - An Indian Cohort Study
-
Frequency and Etiology of Cytogenetically Cryptic Oncogenic Fusions in Pediatric AML
-
Cytogenetics in the Era of Genomics - Invited Speaker Presentation
-
Whole Transcriptome Sequencing as a Diagnostic Tool for AML
-
Integrative Cytogenetic and Molecular Studies Unmasks Chromosomal Mimicry in Hematologic Malignancies
